Retrospective investigation of 120 patients with gastric cancer following surgery by Una Cidon (2012) indicated that the expression of HER-2/neu gene was observed in 7.5% of patients and its positivity was significantly correlated with female gender, intestinal form, and more advanced stages of this cancer. This evidence concerns the gene ERBB2 and cancer.